Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5679003

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of FTase in human DLD-1 cells expressing moderate level of P-gp1 using Ras as substrate assessed as inhibition of substrate post-translation processing in presence of 10% human serum by immunoblot analysis
4
Total Activities
4
Compounds Tested
1
Activity Types
2
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Cell Type DLD-1
Confidence 0 — Uncurated / Unknown
Curated By Autocuration

Target

Unchecked (CHEMBL612545)
Type UNCHECKED

Publication

A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies.
Gu WZ, Joseph I, Wang YC, Frost D, Sullivan GM, Wang L, Lin NH, Cohen J, Stoll VS, Jakob CG, Muchmore SW, Harlan JE, Holzman T, Walten KA, Ladror US, Anderson MG, Kroeger P, Rodriguez LE, Jarvis KP, Ferguson D, Marsh K, Ng S, Rosenberg SH, Sham HL, Zhang H.
Anticancer Drugs (2005) 16 : 1059 -1069
PubMed 16222147 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
EC50 4 8.37 9.40

Assay Parameters

Parameter Type Value Units Text
EFO_ID EFO_ID - MONDO:0004992
EFO_TERM EFO_TERM - cancer

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4586794 ABT-100 1 9.40
CHEMBL289228 TIPIFARNIB 3.0 1 8.51
CHEMBL351706 BMS-214662 1.0 1 7.92
CHEMBL298734 LONAFARNIB 4.0 1 7.64

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4586794 ABT-100 EC50 = 0.4 nM 9.40
CHEMBL289228 TIPIFARNIB EC50 = 3.1 nM 8.51
CHEMBL351706 BMS-214662 EC50 = 12.0 nM 7.92
CHEMBL298734 LONAFARNIB EC50 = 23.0 nM 7.64